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Houston, Texas; and New York, New York
Although coronary angiography has been regarded for 4
decades as the “gold standard” for assessing coronary artery
disease, anyone who has performed or tried to interpret
coronary angiograms becomes aware very quickly that the
technique is subject to several critical limitations. Visualiza-
tion of coronary lesions is often limited by patient morpho-
logical features, and is plagued by abundant evidence of poor
correlation with pathological findings (1) and considerable
interobserver variability with regard to the severity of
coronary arterial narrowings (2,3) and their morphology (4).
Simple categorization of the extent of coronary artery
disease according to the number of diseased vessels was
useful for providing a broad prognostic picture when the
interventions available were limited to bypass surgery or a
small armamentarium of medical therapies, but was of
limited utility when a wider variety of treatment options
became available. It is also well recognized that angio-
graphic grading of lesion severity is at best an imperfect
predictor of the physiological significance (i.e., flow-
limiting status) of coronary lesions (5). Technical features
related to patient morphology or vessel tortuousity can also
limit visualization of specific coronary narrowings.
See page 1211
In preparing a randomized clinical trial of intracoronary
stenting with coronary bypass surgery, the SYNTAX (Syn-
ergy Between PCI With Taxus and Cardiac Surgery)
investigators devised a scoring system that describes the
anatomic complexity of multivessel disease. The score is
based on both the amount of myocardium subtended by the
coronary artery distal to each narrowing 50% in vessels
1.5 mm in diameter and by the anticipated difficulty of
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given lesion, and can be calculated on a public website (6,7).
Within the context of the SYNTAX trial, this system was
able to predict the likelihood of serious events after PCI,
and was useful to stratify differential outcomes between PCI
or coronary bypass graft surgery (8). When stratified into
tertiles using the SYNTAX score, patients with higher
scores had higher adverse event rates after multivessel
stenting, but not after bypass surgery; there were no differ-
ences in outcomes between the 2 treatments in the lowest
tertile, but there were clear differences favoring surgery in
patients in the highest tertile. Although it is clearly an
improvement in classification of risk during and after PCI,
the SYNTAX score has limitations of its own. Interobserver
variability is acceptable, but not outstanding, with weighted
kappa values (a measure of correlation between discontinu-
ous variables) reported at approximately 0.45 to 0.65 (9).
Even more concerning is that agreement on the number of
lesions to be scored (i.e., those 50% narrowed) was
suboptimal (weighted kappa  0.62). Although the calibra-
tion (i.e., the relation between observed and predicted
outcomes) of the SYNTAX score was excellent within the
SYNTAX trial, Capodanno and Tamburino (10) have
pointed out that it has been poor in many other studies but
may be improved when it is combined with clinical risk
scores.
Nearly simultaneously with SYNTAX, in a separate trial,
the FAME (Fractional Flow Reserve versus Angiography in
Multivessel Evaluation) investigators showed that among
patients undergoing multivessel stenting, a strategy of mea-
suring coronary fractional flow reserve (FFR) with a pres-
sure wire and an intravenous infusion of the vasodilator
adenosine led to significant improvements in the practice of
PCI. When FFR is measured, a value 0.80 is an accurate
ndicator that a coronary lesion does not result in ischemia
11). In FAME, “deferred” PCI of lesions with FFR 0.80
ed to implantation of 30% fewer stents per patient, a 28%
eduction in the composite rate of death, myocardial infarc-
ion, or revascularization at the end of a year, and similar
ates of freedom from angina (12). After 2 years, the risk of
eath or myocardial infarction was reduced by 35%. Of the
myocardial infarctions that occurred in patients assigned
o FFR-guided PCI, only 1 could be attributed to a lesion
hat appeared to be severe on coronary angiography (13).
In this issue of the Journal, Nam et al. (14) for the FAME
nvestigators used FFR measurements to refine the SYNTAX
core. Simply, they applied the SYNTAX score based on
uantitative coronary angiography to patients enrolled in
AME, stratified the patients into tertiles of risk based on
he score, and then reclassified the coronary lesions by
ncluding in the score only those lesions with impaired FFR.
herefore, fewer lesions were scored, and the intraobserver
ariability was improved considerably. More important,
atients with angiographically severe but physiologically
nsignificant (as judged by FFR) lesions were reclassified. As
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SYNTAX score (FSS) in which 32% of patients originally
judged to be at high or intermediate risk were moved to
lower risk strata. For the year following PCI, the new score
(the FSS) proved to be a better discriminator than the
SYNTAX score alone of the risk for a composite of death,
myocardial infarction, and target vessel revascularization,
and of a composite of death and myocardial infarction.
Such results ought not to be surprising. If distinguishing
patients according to the presence or absence of flow-
limiting lesions leads to implantation of fewer stents, then
the up-front “cost” of the procedure (i.e., periprocedural
myocardial infarction or stent thrombosis) can be avoided
without impairing the patient’s short-term risk. In light of
the COURAGE (Clinical Outcomes Utilizing Revascular-
ization and Aggressive Drug Evaluation) trial (15) and of
the absence of evidence that prophylactic stenting reduces a
patient’s risk of death or myocardial infarction, most phy-
sicians are likely to accept this finding. The broader question
is whether the FFS will be adopted. Currently, about 6% of
patients undergoing PCI in the United States have FFR
measured before undergoing PCI (16). Although techni-
cally easy to perform, FFR measurement is relatively cum-
bersome and is modestly time consuming—the nursing staff
must mix an adenosine infusion, and procure and load an
infusion pump; the flow wire must be connected to a console
and patient demographic data entered; and the infusion
must be run for 2 min before FFR is measured for each
lesion. Although usually easy to use, the pressure wire does
not share all of the favorable handling characteristics of the
guidewires currently favored by PCI operators. After per-
forming angiography and measuring FFR, an operator
would then have to log into the SYNTAX score website and
enter the appropriate values into the calculator. Although
this series of steps is clearly appropriate in many patients in
whom the coronary anatomy and decision making are
complex, it would prove fairly time consuming in the patient
in whom the decision would seem to be easy to make, or in
whom ad hoc PCI is planned. In addition, although
physicians are reimbursed for measuring FFR on a per vessel
basis, hospitals are not. Finally, in many patients who are
referred for PCI, the flow-limiting capacities of many
arterial lesions may have already been assessed using nuclear
scintigraphy or stress echocardiography.
What is likely to provide incentive to use this technology
more broadly? If the FSS were found useful for deciding
which patients were best served by coronary bypass surgery
and which by PCI, there might be strong motivation to
increase the use of FFR measurement. Although it is very
tempting to apply the findings of Nam et al. (14) to
ituations in which decisions must be made between surgery
nd PCI, it is important to remember that the current
ndings refer only to clinical events at 1 year. Second, and
ost important, the populations studied in SYNTAX and
AME differed, so the risk incurred by patients in the newertiles may be different, and their event rates after bypass wurgery may differ as well. Patients enrolled in FAME were
elected for multivessel PCI, so one assumes that coronary
ypass surgery was already excluded from consideration,
hereas those in SYNTAX were subject to equipoise on the
art of the investigators. Thus, the mean number of angio-
raphic lesions per patient within SYNTAX was 4.3,
hereas in FAME it was 2.8, and the number of total
cclusions in the former study was 23% compared with 9%
n the latter. Nonetheless, the concept of more precise
election of patients for PCI or bypass surgery is attractive.
n fact, assessing lesions for physiological significance may
urn out to be attractive for surgeons as well, since avoiding
he placement of vein grafts to bypass nonobstructive lesions
ight prevent many early graft closures and have a salutary
ffect on the outcome after surgery that parallels the benefit
f the FFR-guided strategy seen in FAME.
Reconciling these findings with the 2 decades of knowl-
dge concerning the need to revascularize all lesions in
atients with multivessel disease may at first seem difficult.
riginally made in patients undergoing bypass surgery,
hese observations have been extended to patients undergo-
ng PCI. Two years ago, Rastan et al. (17) suggested the
erm “reasonable incomplete revascularization,” pointing
ut that revascularization of small vessels, or vessels subten-
ing nonviable territory made little sense. The findings of
am et al. (13) lend credence to the concept that selective
ncomplete revascularization may have advantages, at least
n the intermediate term. It is important to emphasize the
erm “selective.” Unlike previous reports, the lesions for
hich revascularization was “deferred” were not those that
ere inaccessible to PCI or bypass grafting, or for which
here was disagreement about visual interpretations, but
ather were judged objectively to be anatomically but not
hysiologically suitable for stent placement. In nearly all the
etrospective reports, event rates among patients with in-
omplete revascularization were notably worse during the
rst year after the procedure, whereas in FAME, there was
o suggestion of “catch-up” among patients assigned to
eceive stents only if the FFR were 0.80.
Where does this leave us? Development of the SYNTAX
core has provided the beginning of a rational system to
ssess coronary anatomy. It is being tested prospectively in
he EXCEL (Evaluation of Xience Prime versus Coronary
rtery Bypass Surgery for Effectiveness of Left Main
evascularization) trial, which will compare stenting versus
urgery among patients with left main disease with SYNTAX
cores 26. No doubt, EXCEL will provide considerable
uidance in managing this group of patients, but will also
ead to new questions about the treatment strategies. Nam
t al. (14) make a compelling case for integrating physiology
nto this type of assessment. Is the FSS ready for clinical
doption? Probably not. Although measuring FFR is cur-
ently viewed as an established standard for interventional
ardiologists deciding whether or not to implant a stent in
particular vessel, applying this technique to distinguish
hich patients should undergo bypass surgery and to decide
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concept of “watchful waiting” espoused by FAME into a
surgical strategy is intriguing but challenging. Would such a
strategy be broadly applicable, or should it be restricted only
to vessels that could subsequently be approached percuta-
neously if they were to progress or become symptom
producing? Pursuing this course might be more palatable if
we were confident that the likelihood of progression (or
disruption) of anatomically severe but physiologically mild
lesions could be prevented with modern medical therapy.
Gaining such confidence would require several important
steps. Duration of observation of the cohorts defined in the
current study should be extended, and the approach should
be validated in a second database. The next step toward its
adoption would be prospective inclusion into the next
generation of clinical trials comparing physiologic based
stenting with physiologic based bypass surgery. We would
then be ready to apply a more refined standard to selecting
the appropriate revascularization approach for individual
patients.
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